Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Respiratory infection

Original research

Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Strachan R, Homaira N, Beggs S, et al

Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia

Thorax 2021;76:487-493.